StaniPharm is a Contract Development and Manufacturing Organization (CDMO) servicing the life science industries. We are committed to the highest standards in quality, compliance and customer service. Our scientists are adept at solving challenging issues encountered in the development and manufacturing of innovative health products. We bring to your projects over 60 years of combined experience in the development of scalable, GMP compliant and cost-effective supercritical fluid technologies. StaniPharm integrates particle design and purification processes, analytic and clinical trial material manufacturing under one roof. We provide our customers with a flexible and time efficient partner for the refining and repurposing of existing drug substances or the development of new chemical entities or medical products.
| Website | http://www.stanipharm.fr |
| Revenue | $5 million |
| Employees | View employees |
| Industry | Drug Stores & Pharmacies, Retail |
| Competitors | Sanofi, Boehringer Ingelheim, Roche, Mylan Belgium, GSK, Novartis, Teva Pharmaceuticals, Pfizer, AstraZeneca, AbbVie +51 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular StaniPharm employee's phone or email?
StaniPharm Questions
The StaniPharm annual revenue was $5 million in 2026.
The NAICS codes for StaniPharm are [325, 32, 32541, 3254].
The SIC codes for StaniPharm are [283, 28].
